Clinical and laboratorial predictors related to progression to chronic kidney disease in patients with autosomal dominant polycystic kidney disease;Factores clínicos y de laboratorio relacionados con progresión a enfermedad renal crónica en pacientes con enfermedad renal poliquística autosómica dominante

Revista de Investigacion Clinica

Volumn 61, Issue 5, 2009, Pages 364-370

  Dehesa López, Edgar ^a   Pérez Gutiérrez, Rosario Angélica ^a   Valdez Ortiz, Rafael ^a   Morales Buenrostro, Luis Eduardo ^a   Correa Rotter, Ricardo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Advanced chronic kidney disease; Autosomic dominant polycystic kidney disease; Dyslipidemia; Serum creatinine

Indexed keywords

CREATININE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77249171278     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wilson PD. Polycystic kidney disease. N Engl J Med 2004; 350: 151-64.
2. Chang MY, Ong AC. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron Physiol 2008; 108: 1-7.
3. Harris PC. Autosomal dominant polycystic kidney disease: clues to pathogenesis. Hum Mol Genet 1999; 8: 1861-6.
4. Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 1998; 80: 421-7.
5. Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand 1957; 328(Suppl.): 1-255.
6. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983; 2: 630-9.
7. Deirde AO, Vicente ET. Autosomal Dominant Polycystic Kidney Disease. En: Comprehensive clinical nephrology. 3rd Philadelphia, USA: Ed. Mosby; 2007, p. 597-609.
8. Vicente ET, Jared JG. Cystic Diseases of the Kidney. En: Brenner and Rector's The Kidney. 8th Ed. Philadelphia: Saunders Elsevier; 2007, p. 1429-43.
9. Gabow PA, Jonhson AM, Kaenhy WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH. Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-19.
10. Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003; 63: 678-85.
11. Linda FF. Effects of HMG-CoA reductase inhibitors (statins) on progression on kidney disease. Kidney Int 2008; 74: 571-6.
12. Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997; 12: 1908-15.
13. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998; 158: 998-1004.
14. Krolewski AS, Warram JH, Christlieb AR. Hypercholesterolemiaa determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl 1994; 45: S125-S131.
15. Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, et al. Analysis of metabolic parameters as predictors of risk in the RENAAL study. Diabetes Care 2003; 26: 1402-07.
16. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol 2001; 12: 194-200.
17. Johnson AM, Gabow PA. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 1997; 8: 1560-7.
18. Gretz N, Zeier M, Geberth S, Strauch M, Ritz E. Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1989; 14: 178-83.
19. Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 6: 1634-42.
20. Chapman AB, Johnson A, Gabow PA, Schrier RW. The reninangiotensin- aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091-6.